vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Molson Coors Beverage Company (TAP). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $3.1B, roughly 1.8× Molson Coors Beverage Company). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 7.6%, a 0.3% gap on every dollar of revenue. On growth, Fresenius Medical Care AG posted the faster year-over-year revenue change (-0.3% vs -3.6%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Molson Coors Beverage Company is a Canadian-American multinational drink and brewing company headquartered in Chicago, Illinois and Montreal, Quebec.
FMS vs TAP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $3.1B |
| Net Profit | $434.2M | $238.3M |
| Gross Margin | 27.4% | 31.0% |
| Operating Margin | 11.7% | 10.4% |
| Net Margin | 7.9% | 7.6% |
| Revenue YoY | -0.3% | -3.6% |
| Net Profit YoY | 240.4% | -17.2% |
| EPS (diluted) | — | $1.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $3.1B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $5.5B | $3.2B | ||
| Q3 24 | — | $3.6B | ||
| Q2 24 | — | $3.8B | ||
| Q1 24 | — | $3.0B |
| Q4 25 | $434.2M | $238.3M | ||
| Q3 25 | — | $-2.9B | ||
| Q2 25 | — | $428.7M | ||
| Q1 25 | — | $121.0M | ||
| Q4 24 | $127.6M | $287.8M | ||
| Q3 24 | — | $199.8M | ||
| Q2 24 | — | $427.0M | ||
| Q1 24 | — | $207.8M |
| Q4 25 | 27.4% | 31.0% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | — | 34.3% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | 25.0% | 32.0% | ||
| Q3 24 | — | 33.4% | ||
| Q2 24 | — | 34.6% | ||
| Q1 24 | — | 31.6% |
| Q4 25 | 11.7% | 10.4% | ||
| Q3 25 | — | -98.5% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 6.9% | ||
| Q4 24 | 5.1% | 12.0% | ||
| Q3 24 | — | 12.5% | ||
| Q2 24 | — | 15.6% | ||
| Q1 24 | — | 10.3% |
| Q4 25 | 7.9% | 7.6% | ||
| Q3 25 | — | -84.0% | ||
| Q2 25 | — | 11.5% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 2.3% | 8.9% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 6.8% |
| Q4 25 | — | $1.32 | ||
| Q3 25 | — | $-14.79 | ||
| Q2 25 | — | $2.13 | ||
| Q1 25 | — | $0.59 | ||
| Q4 24 | — | $1.39 | ||
| Q3 24 | — | $0.96 | ||
| Q2 24 | — | $2.03 | ||
| Q1 24 | — | $0.97 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $896.5M |
| Total DebtLower is stronger | — | $6.3B |
| Stockholders' EquityBook value | $15.4B | $10.2B |
| Total Assets | $33.5B | $22.7B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $896.5M | ||
| Q3 25 | — | $950.2M | ||
| Q2 25 | — | $613.8M | ||
| Q1 25 | — | $412.7M | ||
| Q4 24 | $1.3B | $969.3M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | — | $458.4M |
| Q4 25 | — | $6.3B | ||
| Q3 25 | — | $6.3B | ||
| Q2 25 | — | $6.3B | ||
| Q1 25 | — | $6.2B | ||
| Q4 24 | — | $6.1B | ||
| Q3 24 | — | $6.2B | ||
| Q2 24 | — | $7.0B | ||
| Q1 24 | — | $6.2B |
| Q4 25 | $15.4B | $10.2B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | — | $13.4B | ||
| Q1 25 | — | $13.1B | ||
| Q4 24 | $17.0B | $13.1B | ||
| Q3 24 | — | $13.3B | ||
| Q2 24 | — | $13.2B | ||
| Q1 24 | — | $13.1B |
| Q4 25 | $33.5B | $22.7B | ||
| Q3 25 | — | $22.9B | ||
| Q2 25 | — | $26.8B | ||
| Q1 25 | — | $25.9B | ||
| Q4 24 | $36.3B | $26.1B | ||
| Q3 24 | — | $26.6B | ||
| Q2 24 | — | $27.4B | ||
| Q1 24 | — | $26.1B |
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.47× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $540.7M |
| Free Cash FlowOCF − Capex | — | $357.8M |
| FCF MarginFCF / Revenue | — | 11.4% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | 6.67× | 2.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $540.7M | ||
| Q3 25 | — | $616.1M | ||
| Q2 25 | — | $718.3M | ||
| Q1 25 | — | $-90.7M | ||
| Q4 24 | $2.6B | $494.5M | ||
| Q3 24 | — | $521.2M | ||
| Q2 24 | — | $869.2M | ||
| Q1 24 | — | $25.4M |
| Q4 25 | — | $357.8M | ||
| Q3 25 | — | $483.0M | ||
| Q2 25 | — | $555.0M | ||
| Q1 25 | — | $-328.0M | ||
| Q4 24 | — | $383.4M | ||
| Q3 24 | — | $350.4M | ||
| Q2 24 | — | $691.7M | ||
| Q1 24 | — | $-189.3M |
| Q4 25 | — | 11.4% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | — | -12.2% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 18.0% | ||
| Q1 24 | — | -6.2% |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 4.4% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 4.7% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 7.0% |
| Q4 25 | 6.67× | 2.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.68× | ||
| Q1 25 | — | -0.75× | ||
| Q4 24 | 20.20× | 1.72× | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | — | 2.04× | ||
| Q1 24 | — | 0.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
